Based in Singapore, Aevice Health specializes in remote monitoring solutions for chronic respiratory conditions. The company's flagship product is the AeviceMD, a wearable smart stethoscope that is worn on the right side of the chest and designed to continuously monitor patients with chronic respiratory diseases. This device analyzes heart and lung sounds while tracking vital biomarkers such as respiratory rate, heart rate, and wheezing. The AeviceMD is connected to a mobile application that notifies users upon detecting unusual breathing patterns that may indicate potential asthma attacks. It also monitors long-term respiratory and heart rate trends, enabling users to react promptly to changes in their condition.
The company's remote monitoring platform allows healthcare professionals to conduct comprehensive lung health assessments remotely, using patients' longitudinal data to detect clinical deterioration early.
Aevice Health has obtained regulatory approvals for the AeviceMD in both the US and Singapore.
Key customers and partnerships
Aevice Health serves primarily within the healthcare sector, including hospitals, clinics, and individual patients managing chronic respiratory diseases.
In February 2024, the company partnered with London-based Jiva.ai to develop an AI system aimed at predicting asthma exacerbations. This collaboration utilizes Jiva.ai's multimodal no-code AI, which can read multiple types of data and make predictions outside of clinical settings.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.